MedTrace Logo

Development of a Mobile Application Called TansiyoRitim for Hypertension Patients

NCT07556419 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2026-06-18

No results posted yet for this study

Summary

Based on King's Theory of Goal Success, this project is designed to develop a mobile application called TansiyoRitim for individuals over the age of 18 diagnosed with hypertension. The research consists of the following phases: creating educational content, designing the mobile application, and evaluating the application and its effectiveness. Within the scope of the research, participants' blood pressure control, self-efficacy levels, and treatment adherence behaviors will be assessed using valid and reliable measurement tools, and the goal is to support these behaviors through the developed mobile health application. Participants' clinical treatment processes, pharmacological treatment adjustments planned by the physician, and changes in medication dosages will be excluded from the scope of the project. No intervention will be made in the medical treatment currently being administered during the study; participants' routine clinical follow-up and treatment processes will continue within the framework of standard care. Only educational and mobile app-based supportive interventions will be implemented within the scope of the research.

Conditions

  • Hypertension
  • Mobile Application
  • Blood Pressure Control
  • Treatment Adherence
  • Self-Efficacy

Interventions

BEHAVIORAL

Mobile application

The mobile application will be developed for patients with hypertension. It will include educational videos, educational texts, and reminders.

BEHAVIORAL

control group

The control group will not be interfered with.

Sponsors & Collaborators

  • Kafkas University

    lead OTHER

Principal Investigators

  • Rabia Bayrambey, 1 · Kafkas University

  • Yeliz Akkuş, 2 · Nigde Omer Halisdemir University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2026-10-30
Completion
2027-03-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07556419 on ClinicalTrials.gov